U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
122521122521A Dose-Ranging Study of MK-5442 in Postmenopausal Women With Osteoporosis (MK-5442-001)TerminatedHas ResultsOsteoporosisDrug: MK-5442|Drug: Placebo|Dietary Supplement: Vitamin D3|Dietary Supplement: Calcium carbonatehttps://ClinicalTrials.gov/show/NCT00960934
122522122522Study of the Effects of Iron on Lung Blood Pressure at High AltitudeSuspendedNo Results AvailableHypertension, PulmonaryDrug: Iron sucrose|Drug: Normal salinehttps://ClinicalTrials.gov/show/NCT00960921
122523122523Registry to Evaluate the Efficacy of Zotarolimus-Eluting StentRecruitingNo Results AvailableCoronary Artery DiseaseDevice: Endeavor Resolute stents|Device: Endeavor Sprint stenthttps://ClinicalTrials.gov/show/NCT00960908
122524122524Pulmonary Hypertension in LymphangioleiomyomatosisCompletedNo Results AvailableLymphangioleiomyomatosis|Pulmonary Hypertensionhttps://ClinicalTrials.gov/show/NCT00960895
122525122525Gastric Tolerability and Pharmacokinetics of DMMET-01CompletedNo Results AvailableHealthyDrug: DMMET-01https://ClinicalTrials.gov/show/NCT00960882
122526122526Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PA32540 or Enteric Coated Aspirin 325 mg in Subjects Who Are at Risk for Developing Aspirin-Associated UlcersCompletedNo Results AvailableGastric UlcerDrug: PA32540|Drug: EC Aspirin 325https://ClinicalTrials.gov/show/NCT00960869
122527122527Four Arm Food Effect Study of Fenofibric Acid TabletsCompletedHas ResultsHealthyDrug: Fenofibric Acid 105 mg Tablet|Drug: Fenofibric Acid 105 mg Tablet|Drug: Fenofibric Acid 105 mg Tablet|Drug: Fenofibric Acid 105 mg Tablethttps://ClinicalTrials.gov/show/NCT00960856
122528122528Six-month Study to Compare the Effects of Volume- and Pressure-Guided Adjustments on Weight Loss and SatietyCompletedHas ResultsMorbid ObesityDevice: Intraband pressure recording system|Other: Conventional Adjustmenthttps://ClinicalTrials.gov/show/NCT00960843
122529122529Mirtazapine Reduces ICD Shocks in ICD Patients With Depression and AnxietyCompletedNo Results AvailableDepression|AnxietyDrug: mirtazapine|Drug: mirtazapinehttps://ClinicalTrials.gov/show/NCT00960830
122530122530"Normal Coronary Artery" With Slow Flow Improved by Adenosine Injection, Dipyridamole Treatment and Clinical Follow-upNot yet recruitingNo Results AvailableCoronary AngiographyDrug: Statin, aspirin|Drug: Dipyridamolehttps://ClinicalTrials.gov/show/NCT00960817
122531122531Long-Term Study Of The Safety Of Tanezumab In Arthritis PatientsTerminatedNo Results AvailableOsteoarthritisBiological: Tanezumab|Biological: Tanezumab|Other: Placebohttps://ClinicalTrials.gov/show/NCT00960804
122532122532Study to Assess the Absorption, Distribution, Metabolism and Excretion of AZD1656 in Type 2 Diabetes Mellitus (T2DM)CompletedNo Results AvailableType II Diabetes MellitusDevice: AZD1656https://ClinicalTrials.gov/show/NCT00960791
122533122533Gender Differences in Response to Nicotine Replacement Therapy and De-Nicotinized CigarettesCompletedNo Results AvailableNicotine DependenceDrug: nicotine patch (Nicoderm CQ, Habitrol)|Other: denicotinized cigarettes (Quest 3 cigarettes)https://ClinicalTrials.gov/show/NCT00960778
122534122534Endotoxin and Intestinal Flora Before and After Gastric Bypass or Banding in DiabeticsRecruitingNo Results AvailableObesity, Morbid|Diabetes Mellitus, Type 2|Gastric Bypasshttps://ClinicalTrials.gov/show/NCT00960765
122535122535Tumor and Vaccine Site With a Toll Like Receptor (TLR) AgonistRecruitingNo Results AvailableMelanomaDrug: gp100|Drug: R848 gel|Drug: MAGE-3https://ClinicalTrials.gov/show/NCT00960752
122536122536Iodobenzylguanidine Meta-I131 and Topotecan in Young Patients With Refractory or Relapsed Metastatic NeuroblastomaRecruitingNo Results AvailableNeuroblastomaDrug: topotecan hydrochloride|Procedure: autologous hematopoietic stem cell transplantation|Radiation: iobenguane I 131|Radiation: total-body irradiationhttps://ClinicalTrials.gov/show/NCT00960739
122537122537NOV-002 in Myelodysplastic Syndrome (MDS)WithdrawnNo Results AvailableLeukemia|Myelodysplastic SyndromeDrug: NOV-002https://ClinicalTrials.gov/show/NCT00960726
122538122538The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune DisordersCompletedNo Results AvailablePemphigus|Auto-immune Thrombocytopenic Purpura|Hemolytic Auto-immune Anaemia|Cold Agglutinin Disease|CryoglobulinemiaDrug: Rituximab (MABTHERA® or RITUXAN®).https://ClinicalTrials.gov/show/NCT00960713
122539122539A Multi Focal Visual Outcome Study Using Different Near AdditionsTerminatedNo Results AvailableCataract|AphakiaDevice: Visual Acuity|Device: Contrast sensitivity|Device: Reading Speed|Procedure: Eye Healthhttps://ClinicalTrials.gov/show/NCT00960700
122540122540Fed Bioequivalence Study of Fenofibric Acid Versus TriCor® (Fenofibrate)CompletedHas ResultsHealthyDrug: Fenofibric Acid (Fibricor™) 105 mg Tablet|Drug: Fenofibrate (Tricor®) 145 mg Tablethttps://ClinicalTrials.gov/show/NCT00960687
122541122541Tactile Massage in Type 2 DiabetesCompletedNo Results AvailableType 2 DiabetesProcedure: Tactile massage|Behavioral: Relaxationhttps://ClinicalTrials.gov/show/NCT00960674
122542122542A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 DiabetesCompletedHas ResultsType 2 Diabetes MellitusDrug: exenatide|Drug: insulin lispro|Drug: Metformin|Drug: Insulin/ Glarginehttps://ClinicalTrials.gov/show/NCT00960661
122543122543Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After StentingActive, not recruitingNo Results AvailableCoronary Artery DiseaseDevice: Xience/Promus|Device: Cypherhttps://ClinicalTrials.gov/show/NCT00960648
122544122544Immunointervention With Calcitriol in New-Onset Type 1 DiabetesCompletedNo Results AvailableType 1 DiabetesDrug: 1,25-dihydroxy-vitamin D3 (calcitriol)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00960635
122545122545Switch From Combivir or Trizivir to Truvada - Mitochondrial EffectsCompletedHas ResultsHIVDrug: Truvada|Drug: Combivir|Drug: Trizivirhttps://ClinicalTrials.gov/show/NCT00960622
122546122546Communicating Veins Between Adjacent Hepatic Veins: an Intra-operative Ultrasound StudyCompletedNo Results AvailableLiver TumorsProcedure: Ultrasound guided liver resectionhttps://ClinicalTrials.gov/show/NCT00960609
122547122547Preventive Medicine Study of Childhood Atopic DiseasesEnrolling by invitationNo Results AvailableHealthyBehavioral: Health promotion and health education for smoking habitshttps://ClinicalTrials.gov/show/NCT00960596
122548122548Economic Evaluation of an Exercise Program After Multidisciplinary Rehabilitation in Patients With Chronic Low Back PainCompletedNo Results AvailableChronic Low Back PainOther: Functional multidisciplinary rehabilitation|Other: Exercise program|Other: Routine follow-uphttps://ClinicalTrials.gov/show/NCT00960583
122549122549Drug-Drug Interaction Study Between Fenofibric Acid and EfavirenzCompletedHas ResultsHealthyDrug: Efavirenz 600 mg|Drug: Efavirenz 600 mg|Drug: Fenofibric Acidhttps://ClinicalTrials.gov/show/NCT00960570
122550122550Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor BurdenCompletedNo Results AvailableNeoplasm MetastasisDrug: Combretastatin A1 Diphosphate (OXi4503)https://ClinicalTrials.gov/show/NCT00960557

* Görseller ve İçerik tekif hakkına sahip olabilir